Therapeutic strategies for HIV infection--time to think hard

Editorial

D A Cooper et al. N Engl J Med. 1998.

. 1998 Oct 29;339(18):1319-21.

doi: 10.1056/NEJM199810293391810.

No abstract available

Comment on

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
Havlir DV, Marschner IC, Hirsch MS, Collier AC, Tebas P, Bassett RL, Ioannidis JP, Holohan MK, Leavitt R, Boone G, Richman DD. Havlir DV, et al. N Engl J Med. 1998 Oct 29;339(18):1261-8. doi: 10.1056/NEJM199810293391801. N Engl J Med. 1998. PMID: 9791141 Clinical Trial.
A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
Pialoux G, Raffi F, Brun-Vezinet F, Meiffrédy V, Flandre P, Gastaut JA, Dellamonica P, Yeni P, Delfraissy JF, Aboulker JP. Pialoux G, et al. N Engl J Med. 1998 Oct 29;339(18):1269-76. doi: 10.1056/NEJM199810293391802. N Engl J Med. 1998. PMID: 9791142 Clinical Trial.